IMMUNITRACK ApS: Financial statements 2019
CVR: 32347908
Source: annual report 2019, Danish Business Authority
01/06/2018 – 31/05/2019
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -457,365 and a net result of DKK -2,303,315 compared with DKK 1,676,895 the year before. Equity in the 2019 report amounted to DKK 6,108,311. The solvency ratio was 68.6%. The company had 6 employees in the financial year.
- Gross Profit
- DKK -457,365
- Profit/Loss
- DKK -2,303,315
- Equity
- DKK 6,108,311
- Total Assets
- DKK 8,901,798
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -457 t. | -2.3 mio. | 6.1 mio. | 6 |
| 2018 | - | 2.5 mio. | 1.7 mio. | 3.5 mio. | 4 |
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company has been dissolved. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees (2018). In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity in the 2024 report amounted to DKK 21,211,816.